[Form 4] Salesforce, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Salesforce (CRM) Form 4: Chair and CEO Marc Benioff reported a same‑day option exercise and sale on 10/09/2025 under a Rule 10b5‑1 trading plan adopted on January 9, 2025. He exercised 2,250 non-qualified stock options at an exercise price of $161.50 per share and sold 2,250 shares in multiple transactions at weighted average prices ranging from $237.6400 to $245.5785.

Following the transactions, Benioff directly held 11,911,571 shares, with additional indirect holdings of 107,000 shares by trust and 10,000,000 shares by Marc Benioff Fund LLC. He also reported 36,122 derivative securities (options) beneficially owned after the transactions.

Insights

Insider trading compliance analyst

Routine 10b5‑1 plan trade; neutral impact.

This filing shows a pre‑planned transaction: exercise of 2,250 options at $161.50 and sale of 2,250 shares across several price bands on 10/09/2025. The Rule 10b5‑1 plan, noted as adopted on January 9, 2025, indicates trades were set in advance.

Post‑trade, the report lists 11,911,571 shares held directly, plus indirect interests of 107,000 (trust) and 10,000,000 (Marc Benioff Fund LLC). The remaining 36,122 options suggest continued equity exposure. These administrative updates typically do not alter the investment thesis.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Benioff Marc

(Last) (First) (Middle)

415 MISSION STREET

3RD FLOOR

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Salesforce, Inc. [ CRM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair and CEO

3. Date of Earliest Transaction (Month/Day/Year)
10/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/09/2025		M(1)		2,250	A	$161.5	11,913,821	D(2)
Common Stock	10/09/2025		S(1)		163	D	$237.9413(3)	11,913,658	D(2)
Common Stock	10/09/2025		S(1)		134	D	$239.4149(4)	11,913,524	D(2)
Common Stock	10/09/2025		S(1)		124	D	$240.3523(5)	11,913,400	D(2)
Common Stock	10/09/2025		S(1)		164	D	$241.7827(6)	11,913,236	D(2)
Common Stock	10/09/2025		S(1)		162	D	$242.5211(7)	11,913,074	D(2)
Common Stock	10/09/2025		S(1)		308	D	$243.7908(8)	11,912,766	D(2)
Common Stock	10/09/2025		S(1)		928	D	$244.7387(9)	11,911,838	D(2)
Common Stock	10/09/2025		S(1)		267	D	$245.4231(10)	11,911,571	D(2)
Common Stock								107,000	I	By Trust
Common Stock								10,000,000	I(11)	By Marc Benioff Fund LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified Stock Option (Right to Buy)	$161.5	10/09/2025		M(1)			2,250	03/22/2020(12)	03/22/2026	Common Stock	2,250	$0	36,122	D

Explanation of Responses:

1. As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2025.

2. Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust.

3. Weighted average price. These shares were sold in multiple transactions at prices ranging from $237.6400 to $238.3520 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

4. Weighted average price. These shares were sold in multiple transactions at prices ranging from $238.9855 to $239.7153 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

5. Weighted average price. These shares were sold in multiple transactions at prices ranging from $240.0056 to $240.9717 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

6. Weighted average price. These shares were sold in multiple transactions at prices ranging from $241.1972 to $242.1192 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

7. Weighted average price. These shares were sold in multiple transactions at prices ranging from $242.2366 to $242.8977 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

8. Weighted average price. These shares were sold in multiple transactions at prices ranging from $243.2510 to $244.1700 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

9. Weighted average price. These shares were sold in multiple transactions at prices ranging from $244.2581 to $245.2313 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

10. Weighted average price. These shares were sold in multiple transactions at prices ranging from $245.2646 to $245.5785 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

11. Shares held in the Marc Benioff Fund LLC (the "Fund"). Fund interests are held in the reporting person's name or in trust.

12. Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

	/s/ Andrew Leeds, Attorney-in-Fact for Marc Benioff	10/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Salesforce (CRM) CEO Marc Benioff report on this Form 4?

He exercised 2,250 options at $161.50 and sold 2,250 shares on 10/09/2025 under a Rule 10b5‑1 plan.

What prices were the Salesforce (CRM) shares sold at?

Weighted average prices ranged from $237.6400 to $245.5785, disclosed across multiple trades.

How many Salesforce (CRM) shares does Marc Benioff hold after the transactions?

He held 11,911,571 shares directly, plus 107,000 by trust and 10,000,000 by Marc Benioff Fund LLC.

Was the Salesforce (CRM) insider trade under a 10b5‑1 plan?

Yes. The filing states the transactions were effected under a Rule 10b5‑1 plan adopted on January 9, 2025.

What derivative securities remain for Marc Benioff at Salesforce (CRM)?

The filing reports 36,122 non‑qualified stock options beneficially owned after the transactions.

What is the option grant’s exercise price and vesting detail?

Exercise price is $161.50. It vested 25% on 03/22/2020, with the remainder vesting monthly over 36 months.